International Journal of Gynecology & Obstetrics
Volume 99, Supplement 2 , Pages S172-S177, December 2007

Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy

  • A. Faúndes

      Affiliations

    • Department of Gynecology and Obstetrics, State University of Campinas (UNICAMP), Campinas, SP, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +55 19 3289 2856; fax: +55 19 3289 2440.
  • ,
  • C. Fiala

      Affiliations

    • Gynmed Clinic, Vienna, Austria
  • ,
  • O.S. Tang

      Affiliations

    • Department of Obstetrics and Gynecology, University of Hong Kong, Hong Kong SAR, China
  • ,
  • A. Velasco

      Affiliations

    • Department of Gynecology and Obstetrics. Hospital Eusebio Hernández (Maternidad Obrera), Havana, Cuba

published online 04 October 2007.

Recommended Dosage

Vaginal misoprostol 800μg 6 hourly x3

Abstract 

The aim was to review the current knowledge about the use of misoprostol alone for abortion induction during the first 12 weeks of pregnancy. Publications reporting experiences with misoprostol alone for pregnancy termination within the first 12 weeks of pregnancy were included in the analysis. Vaginal administration of 800 μg repeated up to three times at 6, 12 or 24 h intervals has an 85% to 90% effectiveness, defined as complete abortion, in most studies. Oral administration is less effective, but sublingual administration at 3-hour interval has the same effectiveness, with more frequent side effects. The oral and sublingual routes appear to be better accepted than vaginal administration. Most studies are limited to the first 9 weeks of pregnancy. The experience on pregnancy termination between 10 and 12 weeks is not yet sufficient for a recommendation.

Keywords: Misoprostol alone, Medical abortion, Effectiveness

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0020-7292(07)00509-7

doi:10.1016/j.ijgo.2007.09.006

International Journal of Gynecology & Obstetrics
Volume 99, Supplement 2 , Pages S172-S177, December 2007